Knowledge, attitude, and uptake related to human papillomavirus vaccination among young women in Germany recruited via a social media site.

PubWeight™: 0.89‹?›

🔗 View Article (PMID 25483492)

Published in Hum Vaccin Immunother on October 30, 2014

Authors

Cornelius Remschmidt1, Dietmar Walter, Patrick Schmich, Matthias Wetzstein, Yvonne Deleré, Ole Wichmann

Author Affiliations

1: a Immunization Unit; Robert Koch Institute ; Berlin , Germany.

Articles cited by this

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet (2009) 13.51

Human papillomavirus and cervical cancer. Lancet (2007) 12.47

Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial. Lancet Oncol (2011) 5.57

Web-based recruiting for health research using a social networking site: an exploratory study. J Med Internet Res (2012) 3.82

Broad reach and targeted recruitment using Facebook for an online survey of young adult substance use. J Med Internet Res (2012) 3.77

Factors associated with HPV vaccine uptake in teenage girls: a systematic review. Vaccine (2012) 2.98

Parental beliefs and decision making about child and adolescent immunization: from polio to sexually transmitted infections. J Dev Behav Pediatr (2005) 2.74

Parental intention to have daughters receive the human papillomavirus vaccine. CMAJ (2007) 1.91

Knowledge about infection with human papillomavirus: a systematic review. Prev Med (2007) 1.75

Population-based prevalence, type- and age-specific distribution of HPV in women before introduction of an HPV-vaccination program in Denmark. Int J Cancer (2008) 1.71

Determinants for HPV vaccine uptake in the Netherlands: A multilevel study. Vaccine (2009) 1.62

Factors affecting transmission of mucosal human papillomavirus. Lancet Infect Dis (2010) 1.56

Human papillomavirus and vaccination: knowledge, attitudes, and behavioural intention in adolescents and young women in Italy. Br J Cancer (2008) 1.27

Knowledge and awareness of HPV and the HPV vaccine among young women in the first routinely vaccinated cohort in England. Vaccine (2012) 1.20

Online advertising to reach and recruit Latino smokers to an internet cessation program: impact and costs. J Med Internet Res (2012) 1.20

Human Papillomavirus awareness, knowledge and vaccine acceptance: a survey among 18-25 year old male and female vocational school students in Berlin, Germany. Eur J Public Health (2011) 1.15

Mostly heterosexual and mostly gay/lesbian: evidence for new sexual orientation identities. Arch Sex Behav (2012) 1.15

Human Papillomavirus prevalence and probable first effects of vaccination in 20 to 25 year-old women in Germany: a population-based cross-sectional study via home-based self-sampling. BMC Infect Dis (2014) 1.12

Self-reported barriers and facilitators to preventive human papillomavirus vaccination among adolescent girls and young women: a systematic review. Prev Med (2013) 1.04

Prevalence of low-risk and high-risk types of human papillomavirus and other risk factors for HPV infection in Germany within different age groups in women up to 30 years of age: an epidemiological observational study. J Med Virol (2010) 1.02

Human papillomavirus and cervical cancer: Gardasil vaccination status and knowledge amongst a nationally representative sample of Australian secondary school students. Vaccine (2010) 1.01

A systematic review of literature about women's knowledge and attitudes toward human papillomavirus (HPV) vaccination. Public Health Nurs (2012) 0.99

Knowledge of human papillomavirus and cervical cancer among young women recruited using a social networking site. Sex Transm Infect (2012) 0.96

The role of social networking sites in medical genetics research. Am J Med Genet A (2013) 0.96

Knowledge, attitude, practice and barriers on vaccination against human papillomavirus infection: a cross-sectional study among primary care physicians in Hong Kong. PLoS One (2013) 0.92

Human papillomavirus vaccine uptake, knowledge and attitude among 10th grade students in Berlin, Germany, 2010. Hum Vaccin Immunother (2012) 0.91

HPV vaccination coverage among women aged 18-20 years in Germany three years after recommendation of HPV vaccination for adolescent girls: results from a cross-sectional survey. Hum Vaccin Immunother (2013) 0.87

Universal immunisation with human papillomavirus (HPV) vaccine among females aged 12-17 recommended in Germany. Euro Surveill (2007) 0.86

Articles by these authors

German outbreak of Escherichia coli O104:H4 associated with sprouts. N Engl J Med (2011) 3.69

Health economics of dengue: a systematic literature review and expert panel's assessment. Am J Trop Med Hyg (2011) 2.05

Dengue incidence in urban and rural Cambodia: results from population-based active fever surveillance, 2006-2008. PLoS Negl Trop Dis (2010) 1.98

Influenza vaccination coverage in the 2004/05, 2005/06, and 2006/07 seasons: a secondary data analysis based on billing data of the German associations of statutory health insurance physicians. Dtsch Arztebl Int (2010) 1.65

Determinants of malaria prophylaxis among German travelers to Kenya, Senegal, and Thailand. J Travel Med (2008) 1.62

Communicable diseases prioritized for surveillance and epidemiological research: results of a standardized prioritization procedure in Germany, 2011. PLoS One (2011) 1.45

Estimation of measles vaccine efficacy and critical vaccination coverage in a highly vaccinated population. J R Soc Interface (2010) 1.35

Cost of dengue and other febrile illnesses to households in rural Cambodia: a prospective community-based case-control study. BMC Public Health (2009) 1.27

The efficacy and duration of vaccine protection against human papillomavirus: a systematic review and meta-analysis. Dtsch Arztebl Int (2014) 1.26

Monitoring pandemic influenza A(H1N1) vaccination coverage in Germany 2009/10 - results from thirteen consecutive cross-sectional surveys. Vaccine (2011) 1.21

Human Papillomavirus prevalence and probable first effects of vaccination in 20 to 25 year-old women in Germany: a population-based cross-sectional study via home-based self-sampling. BMC Infect Dis (2014) 1.12

Barriers to pandemic influenza vaccination and uptake of seasonal influenza vaccine in the post-pandemic season in Germany. BMC Public Health (2012) 1.09

Seasonal influenza vaccine uptake in Germany 2007/2008 and 2008/2009: results from a national health update survey. Vaccine (2011) 1.09

The relation between dietary protein, calcium and bone health in women: results from the EPIC-Potsdam cohort. Ann Nutr Metab (2005) 1.05

Epidemiology and cost of herpes zoster and postherpetic neuralgia in Germany. Eur J Health Econ (2012) 1.05

Molecular surveillance of drug resistance through imported isolates of Plasmodium falciparum in Europe. Malar J (2002) 1.04

Determinants of tetanus and seasonal influenza vaccine uptake in adults living in Germany. Hum Vaccin (2011) 1.02

Closer to the goal: efforts in measles elimination in Germany 2010. J Infect Dis (2011) 1.01

Herpes zoster in Germany: quantifying the burden of disease. BMC Infect Dis (2011) 0.99

Operationalizing multimorbidity and autonomy for health services research in aging populations--the OMAHA study. BMC Health Serv Res (2011) 0.93

Molecular and serologic markers of acute dengue infection in naive and flavivirus-vaccinated travelers. Diagn Microbiol Infect Dis (2009) 0.92

Molecular surveillance of circulating dengue genotypes through European travelers. J Travel Med (2011) 0.92

Human papillomavirus vaccine uptake, knowledge and attitude among 10th grade students in Berlin, Germany, 2010. Hum Vaccin Immunother (2012) 0.91

Will dengue vaccines be used in the public sector and if so, how? Findings from an 8-country survey of policymakers and opinion leaders. PLoS Negl Trop Dis (2013) 0.91

Rotavirus vaccine effectiveness and case-control study on risk factors for breakthrough infections in Germany, 2010-2011. Pediatr Infect Dis J (2013) 0.90

Health economic evaluation of vaccination strategies for the prevention of herpes zoster and postherpetic neuralgia in Germany. BMC Health Serv Res (2013) 0.89

Evidence-based decision-making in infectious diseases epidemiology, prevention and control: matching research questions to study designs and quality appraisal tools. BMC Med Res Methodol (2014) 0.88

Prevalence and comorbidity of diabetes mellitus among non-institutionalized older adults in Germany - results of the national telephone health interview survey 'German Health Update (GEDA)' 2009. BMC Public Health (2013) 0.88

Sexual behavior and factors associated with young age at first intercourse and HPV vaccine uptake among young women in Germany: implications for HPV vaccination policies. BMC Public Health (2014) 0.88

HPV vaccination coverage among women aged 18-20 years in Germany three years after recommendation of HPV vaccination for adolescent girls: results from a cross-sectional survey. Hum Vaccin Immunother (2013) 0.87

Epidemiology of invasive meningococcal disease in Germany, 2002-2010, and impact of vaccination with meningococcal C conjugate vaccine. J Infect (2012) 0.87

Forecasting dengue vaccine demand in disease endemic and non-endemic countries. Hum Vaccin (2010) 0.87

Effectiveness of the AS03-adjuvanted vaccine against pandemic influenza virus A/(H1N1) 2009--a comparison of two methods; Germany, 2009/10. PLoS One (2011) 0.86

Risk and spectrum of diseases in travelers to popular tourist destinations. J Travel Med (2005) 0.85

Effectiveness and timing of vaccination during school measles outbreak. Emerg Infect Dis (2012) 0.85

Vaccines for the prevention of seasonal influenza in patients with diabetes: systematic review and meta-analysis. BMC Med (2015) 0.83

Serological evidence of asymptomatic infections during Escherichia coli O104:H4 outbreak in Germany in 2011. PLoS One (2013) 0.83

Risk factors for cervical human papillomavirus infection and high-grade intraepithelial lesion in women aged 20 to 31 years in Germany. Int J Gynecol Cancer (2013) 0.82

Seroprevalence study of Francisella tularensis among hunters in Germany. FEMS Immunol Med Microbiol (2008) 0.82

Impact of rotavirus vaccination in regions with low and moderate vaccine uptake in Germany. Hum Vaccin Immunother (2012) 0.82

Evaluation of a temporary vaccination recommendation in response to an outbreak of invasive meningococcal serogroup C disease in men who have sex with men in Berlin, 2013-2014. Euro Surveill (2016) 0.80

Antibodies against Rickettsia spp. in hunters, Germany. Emerg Infect Dis (2008) 0.80

Lessons from a one-year hospital-based surveillance of acute respiratory infections in Berlin- comparing case definitions to monitor influenza. BMC Public Health (2012) 0.79

Report on the 1st international workshop on procedures for the development of evidence-based vaccination recommendations, Berlin, Germany, 22-23 November 2010. Vaccine (2011) 0.79

Prospective hospital-based case-control study to assess the effectiveness of pandemic influenza A(H1N1)pdm09 vaccination and risk factors for hospitalization in 2009-2010 using matched hospital and test-negative controls. BMC Infect Dis (2012) 0.77

Bayesian parameter inference for dynamic infectious disease modelling: rotavirus in Germany. Stat Med (2014) 0.76

Effectiveness of routine and booster pertussis vaccination in children and adolescents, federal state of Brandenburg, Germany, 2002-2012. Pediatr Infect Dis J (2015) 0.76

[Polio vaccination: a commentary]. Dtsch Med Wochenschr (2016) 0.75

In reply. Dtsch Arztebl Int (2015) 0.75

Risk of Intussusception After Rotavirus Vaccination. Dtsch Arztebl Int (2017) 0.75

Marked Under-Reporting of Pertussis Requiring Hospitalization in Infants as Estimated by Capture-Recapture Methodology, Germany, 2013-2015. Pediatr Infect Dis J (2017) 0.75

Assessment of the human medical significance of the rabies zoonosis in Germany--analysis of available data and desiderata. Berl Munch Tierarztl Wochenschr (2012) 0.75

[From the licensure of vaccines to the recommendation of the Standing Committee on Vaccination in Germany : criteria for the assessment of benefits and risks]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz (2015) 0.75

[Recommendations of the Vaccine Standards Commission of the Robert Koch Institute]. Pharm Unserer Zeit (2008) 0.75